More Complaints Arriving about AndroDerm Testosterone Patches
Each year, many medical device and product lawsuits hit the news. Often, the medical devices or products are somehow defective, and that’s what a New York man claims in his liability suit against Actavis and Watson. The man claims that the side effects of their testosterone patch AndroDerm, was the reason he suffered a stroke. He claims that the company that makes the drug did not do enough to warn men about the possible side effects and risks that using testosterone replacement could cause.
On April 18, 2014, the man, Wesley Davis, filed the complaint along with his wife with the U.S. District Court for the District of Nevada. Davis is certainly not the first person to find issues with testosterone replacement therapy. In fact, a large number of people are starting to file lawsuits against manufacturers who make a variety of different testosterone replacement therapy products and treatment types.
What Is AndroDerm?
The AndroDerm patch is actually one of the first testosterone therapies to come onto the market, and it’s been in use for nearly two decades. The patch is a treatment for low testosterone caused by certain medical conditions. The testosterone medicine is in the form of a patch that the patient will wear on the skin. The patch transmits the testosterone transdermally. It works similarly to a nicotine patch that someone might use to quit smoking. The difference is that this patch delivers testosterone. The patient can put the patch on their arms, back, thighs, or even their stomach.
This particular patch also happens to be one of the best-selling testosterone products in the country. In 2001, their sales were more than $87 million. In all, the products in this field account for more than $2 billion annually. This means that many men might be using a potentially dangerous product right now without realizing the damage they could be doing to their bodies.
In Davis’s lawsuit, he says that his doctor prescribed the medication to help him deal with, in his own words, “the woes of aging he was feeling”. The doctor felt that those feelings were possibly due to diminished testosterone. He started using the patch and subsequently suffered a massive stroke in April of 2011. This severe stroke left Davis with massive medical expenses, as well as permanent physical damage that changed his life.
The lawsuit claims that the advertising push from Actavis and Watson was partly to blame. The advertisements told men that if they were feeling tired, depressed, or if they did not have the same sexual drive, they might be suffering the effects of low testosterone. It urged them to get a blood test to see if they had low testosterone.
More Complaints Arriving All the Time
Davis, as mentioned, is certainly not alone in his complaints against these manufacturers. Many complaints against these companies have been building over the past few months as men across the country are starting to suffer from a variety of issues, including stroke and heart issues. The complaints generally cite that the makers of these products did not do a good enough job when it comes to warning people about the dangers of using testosterone products. They did not mention the common risks, such as heart attack, stroke, blood clots, and even death.
Anyone who has used this product in the past, or who is currently using it, may want to seek a checkup with a medical professional. Those who have suffered from complications using testosterone treatment products should get in touch with an attorney who can determine whether they have a legitimate case and help them file their own lawsuit.
Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.
News Tags
- urgent
Have you been affected by a drug or device listed?
You May Be Eligible for Compensation.
If you or a loved one suffered injury or death after using a drug or medical device, contact us today for a free case evaluation.
We value your privacy. By submitting this form, you agree to our privacy policy and disclaimer.